SCHEMBL6722086

SCHEMBL6722086

CCNC(Cc1ccc(OCCNC(=O)c2ccc(-c3ccccc3)cc2)cc1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.53
RAB9A P51151 10/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
HPGD P15428 1/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
MAPT P10636 2/20 0.53
NFKB1 P19838 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
POLB P06746 1/20 0.52
CASP3 P42574 1/20 0.52
SENP7 Q9BQF6 1/20 0.52
PPARG P37231 3/20 0.50
PPARA Q07869 2/20 0.50
ITGB3 P05106 1/20 0.50
ITGA2B P08514 1/20 0.50
PPARD Q03181 1/20 0.50
KLKB1 P03952 1/20 0.48
HDAC3 O15379 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6722571 0.93 PPARG (0.58) NPC1RAB9ASMN1; SMN2HPGDMEN1
SCHEMBL6713446 0.91 PPARG (0.52) NPC1RAB9ASMN1; SMN2HPGDMEN1
Hydrochloric Acid SCHEMBL6713300 0.90 NPC1 (0.50) NPC1RAB9ASMN1; SMN2HPGDMEN1
SCHEMBL6722528 0.86 PPARG (0.57) NPC1RAB9ASMN1; SMN2HPGDMEN1
SCHEMBL6713130 0.84 PPARG (0.54) NPC1RAB9ASMN1; SMN2HPGDMEN1
SCHEMBL6713122 0.84 PPARG (0.54) NPC1RAB9ASMN1; SMN2HPGDMEN1
SCHEMBL6716114 0.83 NPC1 (0.51) NPC1RAB9ASMN1; SMN2HPGDMEN1
Hydrochloric Acid SCHEMBL6722311 0.83 NPC1 (0.51) NPC1RAB9ASMN1; SMN2HPGDMEN1
SCHEMBL6718066 0.82 NPC1 (0.58) NPC1RAB9ASMN1; SMN2HPGDMEN1
SCHEMBL6714967 0.82 PPARG (0.65) NPC1RAB9ASMN1; SMN2HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 NPC1 812/4885RAB9A 3140/4885SMN1; SMN2 4310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.